Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Oral Contraceptive Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.
This report presents the market size and development trends by detailing the Oral Contraceptive Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oral Contraceptive Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oral Contraceptive Drugs industry and will help you to build a panoramic view of the industrial development.
Oral Contraceptive Drugs Market, By Type:
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Oral Contraceptive Drugs Market, By Application:
Hospital
Pharmacy
Other
Some of the leading players are as follows:
Gedeon Richter
Huazhong
ZiZhu
Merck
Teva Pharmaceutical
Actavis
Pfizer
Bayer
Baijingyu
Johnson & Johnson
Novo Nordisk A/S
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Oral Contraceptive Drugs Market: Technology Type Analysis
-
4.1 Oral Contraceptive Drugs Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Oral Contraceptive Drugs Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Long-acting Contraceptives
4.3.2 Short-acting Contraceptives
4.3.3 Emergency Contraceptives
5 Oral Contraceptive Drugs Market: Product Analysis
-
5.1 Oral Contraceptive Drugs Product Market Share Analysis, 2018 & 2026
-
5.2 Oral Contraceptive Drugs Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Oral Contraceptive Drugs Market: Application Analysis
-
6.1 Oral Contraceptive Drugs Application Market Share Analysis, 2018 & 2026
-
6.2 Oral Contraceptive Drugs Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital
6.3.2 Pharmacy
6.3.3 Other
7 Oral Contraceptive Drugs Market: Regional Analysis
-
7.1 Oral Contraceptive Drugs Regional Market Share Analysis, 2018 & 2026
-
7.2 Oral Contraceptive Drugs Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Gedeon Richter
9.1.1 Gedeon Richter Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Huazhong
9.2.1 Huazhong Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 ZiZhu
9.3.1 ZiZhu Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Merck
9.4.1 Merck Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Teva Pharmaceutical
9.5.1 Teva Pharmaceutical Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Actavis
9.6.1 Actavis Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Pfizer
9.7.1 Pfizer Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Bayer
9.8.1 Bayer Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Baijingyu
9.9.1 Baijingyu Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Johnson & Johnson
9.10.1 Johnson & Johnson Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Novo Nordisk A/S
9.11.1 Novo Nordisk A/S Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 60 Figures and 144 Tables)
Figure Long-acting Contraceptives Oral Contraceptive Drugs market, 2015 - 2026 (USD Million)
Figure Short-acting Contraceptives Oral Contraceptive Drugs market, 2015 - 2026 (USD Million)
Figure Emergency Contraceptives Oral Contraceptive Drugs market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Pharmacy market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Oral Contraceptive Drugs market, by country, 2015 - 2026 (USD Million)
-
Table North America Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table North America Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table North America Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Canada Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Canada Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Europe Oral Contraceptive Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Europe Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Europe Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Europe Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Germany Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Germany Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table France Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table France Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Italy Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Italy Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Spain Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Spain Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Contraceptive Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table China Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table China Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Japan Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Japan Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table India Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table India Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Oral Contraceptive Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table MEA Oral Contraceptive Drugs market, by country, 2015 - 2026 (USD Million)
-
Table MEA Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table MEA Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table MEA Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Oral Contraceptive Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Oral Contraceptive Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Oral Contraceptive Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Gedeon Richter Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Huazhong Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ZiZhu Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Actavis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Baijingyu Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novo Nordisk A/S Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
